Literature DB >> 15551385

A promising peptide antibiotic from Terfezia claveryi aqueous extract against Staphylococcus aureus in vitro.

S Janakat1, S Al-Fakhiri, A-K Sallal.   

Abstract

The antimicrobial activity of aqueous and methanolic extracts, as well as partially purified proteins extracted from Terfezia claveryi aqueous extract were investigated against Staphylococcus aureus in vitro. A 5% aqueous extract inhibited the growth of S. aureus by 66.4%, while a methanolic extract was ineffective. Partial protein purification of the aqueous extract using ammonium sulphate precipitation revealed that antimicrobial activity was within the third fraction. This fraction was then subjected to gel filtration using Sephadex G-100. Two peaks were obtained. Peak one possessed higher antimicrobial activity. This peak was then subjected to ion exchange chromatography using DEAE Sephadex. Only peak 4 from the six peaks obtained showed a slight antimicrobial activity. Antimicrobial activities of the aqueous extract and the fractions that showed antimicrobial activity were compared with reference antibiotics. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15551385     DOI: 10.1002/ptr.1563

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  3 in total

1.  Antimicrobial efficacy of extracts of Saudi Arabian desert Terfezia claveryi truffles.

Authors:  Hani M J Khojah; Osama B Abdelhalim; Mahmoud A H Mostafa; El-Sayed E Habib
Journal:  Saudi J Biol Sci       Date:  2022-09-27       Impact factor: 4.052

Review 2.  Mushrooms: a potential natural source of anti-inflammatory compounds for medical applications.

Authors:  Elsayed A Elsayed; Hesham El Enshasy; Mohammad A M Wadaan; Ramlan Aziz
Journal:  Mediators Inflamm       Date:  2014-11-23       Impact factor: 4.711

Review 3.  Mushrooms and truffles: historical biofactories for complementary medicine in Africa and in the middle East.

Authors:  Hesham El Enshasy; Elsayed A Elsayed; Ramlan Aziz; Mohamad A Wadaan
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-20       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.